8026 - 8050 of 9030 Results
Title
Year
-
OPENTitle: Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 107Issue #: 3Start Page: 553End Page: 562Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.1634Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7939141Citation Count: 19
-
OPENTitle: Inhibition of autophagic flux by S-nitrosylation of SQSTM1/p62 promotes neuronal secretion and cell-to-cell transmission of SNCA/α-synuclein in Parkinson disease and Lewy body dementiaJournal Name: Autophagy ReportsPublisher: Informa UK LimitedVol: 1Issue #: 1Start Page: 223End Page: 225Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/27694127.2022.2076770Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/27694127.2022.2076770?needAccess=trueCitation Count: 7
- What Parkinson's disease patients say in their own words about their mood and anxiety symptoms2024RESTRICTEDTitle: What Parkinson's disease patients say in their own words about their mood and anxiety symptomsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 130Issue #:Start Page: 107190End Page: 107190Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107190Citation Count: 3
- Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease2018RESTRICTEDTitle: Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 136Issue #: 4Start Page: 621End Page: 639Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-018-1892-1Citation Count: 64
- Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities2013RESTRICTEDTitle: Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunitiesJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 12Issue #: 5Start Page: 514End Page: 524Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70047-4Citation Count: 153
-
OPENTitle: Quantitative intravital imaging in zebrafish reveals in vivo dynamics of physiological-stress-induced mitophagyJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 134Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/jcs.256255Best OA location URL: https://journals.biologists.com/jcs/article-pdf/134/4/jcs256255/1822504/jcs256255.pdfCitation Count: 61
-
OPENTitle: Dual role of USP 30 in controlling basal pexophagy and mitophagyJournal Name: The EMBO ReportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embr.201745595Best OA location URL: https://doi.org/10.15252/embr.201745595Citation Count: 163
-
OPENTitle: Effects of Excess Brain-Derived Human α-Synuclein on Synaptic Vesicle TraffickingJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page: 639414End Page: 639414Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.639414Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.639414/pdfCitation Count: 20
-
OPENTitle: Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacyJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 12Start Page: 2915End Page: 2919Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.04.041Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4899947Citation Count: 3
-
OPENTitle: Influence of species and processing parameters on recovery and content of brain tissue‐derived extracellular vesiclesJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 9Issue #: 1Start Page: 1785746End Page: 1785746Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/20013078.2020.1785746Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1080/20013078.2020.1785746Citation Count: 122
- Fidelity of frequency and phase entrainment of circuit-level spike activity during DBS2015RESTRICTEDTitle: Fidelity of frequency and phase entrainment of circuit-level spike activity during DBSJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 114Issue #: 2Start Page: 825End Page: 834Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1152/jn.00259.2015Citation Count: 48
- Genetic disruption of the nuclear receptor Nur77 (Nr4a1) in rat reduces dopamine cell loss and l-Dopa-induced dyskinesia in experimental Parkinson's disease2018RESTRICTEDTitle: Genetic disruption of the nuclear receptor Nur77 (Nr4a1) in rat reduces dopamine cell loss and l-Dopa-induced dyskinesia in experimental Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 304Issue #:Start Page: 143End Page: 153Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.03.008Citation Count: 31
-
OPENTitle: Genetic Evidence Supporting a Causal Role of Depression in Alzheimer’s DiseaseJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 92Issue #: 1Start Page: 25End Page: 33Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2021.11.025Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9200901Citation Count: 65
-
OPENTitle: Clinical and anatomical predictors for freezing of gait and falls after subthalamic deep brain stimulation in Parkinson's disease patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 91End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.021Best OA location URL: http://www.prd-journal.com/article/S1353802019300215/pdfCitation Count: 55
-
OPENTitle: PINK 1 autophosphorylation is required for ubiquitin recognitionJournal Name: The EMBO ReportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embr.201744981Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embr.201744981Citation Count: 117
-
OPENTitle: Il-10 signaling reduces survival in mouse models of synucleinopathyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 30End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00169-8Best OA location URL: https://www.nature.com/articles/s41531-021-00169-8.pdfCitation Count: 12
-
OPENTitle: Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic casesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 58Issue #:Start Page: 183End Page: 190Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2013.05.017Best OA location URL: http://infoscience.epfl.ch/record/189244Citation Count: 59
- Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's Disease2020RESTRICTEDTitle: Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 178End Page: 187Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28299Citation Count: 49
-
OPENTitle: Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegenerationJournal Name: PLOS GeneticsPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 4Start Page: e1010138End Page: e1010138Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1010138Best OA location URL: https://doi.org/10.1371/journal.pgen.1010138Citation Count: 9
-
OPENTitle: TMEM230 in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 56Issue #:Start Page: 212.e1End Page: 212.e3Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.03.014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5526081Citation Count: 9
-
OPENTitle: Rapid 2D 23Na MRI of the calf using a denoising convolutional neural networkJournal Name: Magnetic Resonance ImagingPublisher: Elsevier BVVol: 110Issue #:Start Page: 184End Page: 194Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.mri.2024.04.027Best OA location URL: https://doi.org/10.1016/j.mri.2024.04.027Citation Count: 5
- Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson Disease2020OPENTitle: Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page: 370End Page: 370Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00370Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00370/pdfCitation Count: 13
- No evidence for toxicity after long-term photobiomodulation in normal non-human primates2017RESTRICTEDTitle: No evidence for toxicity after long-term photobiomodulation in normal non-human primatesJournal Name: Experimental Brain ResearchPublisher: Springer Science and Business Media LLCVol: 235Issue #: 10Start Page: 3081End Page: 3092Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00221-017-5048-7Citation Count: 41
-
OPENTitle: Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primatesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 47End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s40478-017-0451-7Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0451-7Citation Count: 57
-
OPENTitle: Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau ProtofibrilsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 18Start Page: 3528End Page: 3539Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.3c00437Best OA location URL: https://doi.org/10.1021/acschemneuro.3c00437Citation Count: 19